Current Opinion in Oncology (COO)

This reader-friendly, bimonthly resource provides a powerful, broad-based perspective on the most important advances from throughout the world literature. Featuring renowned guest editors and focusing exclusively on one to three topics, every issue of Current Opinion in Oncology delivers unvarnished, expert assessments of developments from the previous year. Insightful editorials and on-the-mark invited reviews cover key subjects such as leukemia, endocrine tumors, cancer biology, transplantation, lung and mediastinum, melanoma and other skin neoplasms and the brain and nervous system.

Current Opinion in Oncology (COO) is :-

• International, Peer-Reviewed, Open Access, Refereed, Oncology, cancer biology, clinical oncology, treatment strategies, solid tumors, hematologic malignancies, immunotherapy, targeted therapies, radiation oncology, surgical oncology, supportive care, oncologists, hematologists, surgeons, radiologists, allied health professionals , Online or Print , Bi-Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1040-8746, E-ISSN: 1531-703X, Established: 1989, Impact Factor: 2.4
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE